|
Jan 17
|
Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia
|
|
Jan 16
|
Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock
|
|
Jan 16
|
CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia
|
|
Jan 16
|
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
|
|
Jan 15
|
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
|
|
Jan 15
|
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
|
|
Jan 15
|
Down 88%, Could Editas Medicine Be a Good Investment Now?
|
|
Jan 14
|
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?
|
|
Jan 14
|
My 5 Top Growth Stocks to Buy Hand Over Fist for 2024
|
|
Jan 13
|
The Top Healthcare Stocks to Buy With $100
|
|
Jan 13
|
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
|
|
Jan 10
|
3 Cathie Wood Stocks to Start Off Your New Year Right
|
|
Jan 9
|
CRISPR Therapeutics AG (CRSP) Stock Moves -0.1%: What You Should Know
|
|
Jan 1
|
3 No-Brainer Growth Stocks to Buy for Less Than $100
|
|
Dec 31
|
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024
|
|
Dec 31
|
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
|
|
Dec 30
|
3 Stocks That Could Be Monster Winners in 2024
|
|
Dec 15
|
Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock?
|
|
Dec 15
|
Where Will CRISPR Therapeutics Be in 5 Years?
|
|
Dec 15
|
After This Landmark Win, Is CRISPR Therapeutics a Buy?
|